Loading...

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

This review describes the preclinical mechanisms that may underlie the increased therapeutic benefit of combination therapy—with the N-methyl-d-aspartate receptor antagonist, memantine, and an acetylcholinesterase inhibitor (AChEI)—for the treatment of Alzheimer’s disease (AD). Memantine, and the AC...

Full description

Saved in:
Bibliographic Details
Main Authors: Parsons, Chris G., Danysz, Wojciech, Dekundy, Andrzej, Pulte, Irena
Format: Artigo
Language:Inglês
Published: Springer US 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753463/
https://ncbi.nlm.nih.gov/pubmed/23657927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12640-013-9398-z
Tags: Add Tag
No Tags, Be the first to tag this record!